At Close: 4:00 PM
Kamada Stock Price Graph
Kamada Stock Price Today
Kamada Ltd. (KMDA) stock rallied over 2.12% intraday to trade at $4.82 a share on NASDAQ. The stock opened with a loss of -11.53% at $4.22 and touched an intraday high of $4.31, rising 1.05% against the last close of $4.77. The Kamada Ltd. in stock market went to a low of $4.15 during the session.
Kamada Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
Kamada Stock Price History Chart
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN for Allergic rhinitis and Urticaria; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for cytomegalovirus virus; RUCONEST for angioedema attacks; heparin sodium injection for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. Further, it offers IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis ; and ELIGARD for prostate cancer. The company markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceuticals Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.
Frequently Asked Questions
What is the current Kamada Ltd. (KMDA) stock price?
Kamada Ltd. (NASDAQ: KMDA) stock price is $4.82 in the last trading session. During the trading session, KMDA stock reached the peak price of $4.31 while $4.15 was the lowest point it dropped to. The percentage change in KMDA stock occurred in the recent session was 2.12% while the dollar amount for the price change in KMDA stock was $0.10.
KMDA's industry and sector of operation?
The NASDAQ listed KMDA is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector. Kamada Ltd. provides plasma-derived protein therapeutics.
Who are the executives of KMDA?
Ms. Yifat Philip Esq.
Vice President of Legal, Gen. Counsel & Corporation Sec.
Ms. Ariella Raban
Vice President of HR
Mr. Boris Gorelik
Vice President of Bus. Devel. & Strategic Programs
Ms. Yifat Philip Esq.
VP of Legal, Gen. Counsel & Corp. Sec.
How KMDA did perform over past 52-week?
KMDA's closing price is 0.31% higher than its 52-week low of $3.72 where as its distance from 52-week high of $5.85 is -0.10%.
How many employees does KMDA have?
Number of KMDA employees currently stands at N/A. KMDA operates from 2 Holzman Street, Rehovot, 7670402, IL.
Link for KMDA official website?
Official Website of KMDA is: https://www.kamada.com
How do I contact KMDA?
How many shares of KMDA are traded daily?
KMDA stock volume for the day was 11222.00 shares. The average number of KMDA shares traded daily for last 3 months was 20.4 Thousands.
What is the market cap of KMDA currently?
The market value of KMDA currently stands at $274.99 Million with its latest stock price at $4.82 and N/A of its shares outstanding.